tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
KROS
Keros Therapeutics
RESEARCH TOOLSreports
Want to see KROS full AI Analyst Report?

Keros Therapeutics (KROS) Income Statement

365 Followers

Keros Therapeutics Income Statement

Last quarter (Q1 2026), Keros Therapeutics's total revenue was $367.00K, a decrease of -99.83% from the same quarter last year. In Q1, Keros Therapeutics's net income was $-23.71M. See Keros Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 244.06M$ 3.55M$ 151.00K$ 0.00$ 20.10M
Gross Profit
$ 242.55M$ 3.55M$ 151.00K$ 0.00$ 20.10M
Operating Expenses
$ 171.93M$ 214.38M$ 170.09M$ 114.79M$ 76.47M
Depreciation and Amortization
$ 1.51M$ 1.23M$ 815.00K$ 674.00K$ 378.00K
EBITDA
$ 72.13M$ -185.82M$ -152.18M$ -104.00M$ -56.35M
Operating Income
$ 70.62M$ -210.83M$ -169.94M$ -114.79M$ -56.37M
Other Income/Expenses
$ 21.27M$ 23.78M$ 16.95M$ 10.11M$ -360.00K
Pretax Income
$ 91.90M$ -187.05M$ -152.99M$ -104.68M$ -56.73M
Net Income
$ 87.01M$ -187.35M$ -152.99M$ -104.68M$ -58.74M
Per Share Metrics
Basic EPS
$ 2.34$ -5.00$ -5.20$ -4.15$ -2.52
Diluted EPS
$ 2.30$ -5.00$ -5.20$ -4.15$ -2.52
Weighted Average Shares Outstanding
 37.22M 37.44M 29.45M 25.24M 23.33M
Weighted Average Shares Outstanding (Diluted)
 37.86M 37.44M 29.45M 25.24M 23.33M
Currency in USD

Keros Therapeutics Earnings and Revenue History